Last 12 months
Inside the activity.
16 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 3 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2024 Filed Feb 20, 2024 23:32 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,078 | $1.01 | $1,088.78 |
DisclosureSEC source: 0001753926-24-000345 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 727,608 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| February 09, 2024 Filed Feb 10, 2024 01:02 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,071 | $1.01 | $1,081.71 |
DisclosureSEC source: 0001753926-24-000261 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 726,530 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:02 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,119 | $1.01 | $1,130.19 |
DisclosureSEC source: 0001753926-24-000261 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 725,459 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| February 06, 2024 Filed Feb 6, 2024 23:35 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 56 | $1.01 | $56.56 |
DisclosureSEC source: 0001753926-24-000224 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 724,340 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| February 05, 2024 Filed Feb 6, 2024 23:35 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,939 | $1.01 | $1,958.39 |
DisclosureSEC source: 0001753926-24-000224 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 724,284 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 01:04 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 100 | $1.01 | $101.00 |
DisclosureSEC source: 0001753926-24-000210 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 722,345 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 23:31 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 834 | $1.01 | $842.34 |
DisclosureSEC source: 0001753926-24-000164 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 722,245 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 22, 2024 Filed Jan 22, 2024 23:54 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 7,620 | $1.01 | $7,696.20 |
DisclosureSEC source: 0001753926-24-000131 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 721,411 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 19, 2024 Filed Jan 20, 2024 00:27 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 77 | $1.01 | $77.77 |
DisclosureSEC source: 0001753926-24-000128 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 713,791 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 18, 2024 Filed Jan 20, 2024 00:27 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 999 | $1.01 | $1,008.99 |
DisclosureSEC source: 0001753926-24-000128 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 713,714 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 16, 2024 Filed Jan 17, 2024 00:24 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 13,067 | $1.01 | $13,197.67 |
DisclosureSEC source: 0001753926-24-000109 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 712,715 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 01:10 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 6,731 | $1.08 | $7,269.48 |
DisclosureSEC source: 0001753926-24-000081 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 699,648 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 23:57 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 2,000 | $1.08 | $2,160.00 |
DisclosureSEC source: 0001753926-24-000066 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 692,917 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 23:57 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 4,200 | $1.07 | $4,494.00 |
DisclosureSEC source: 0001753926-24-000066 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 690,917 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 01:40 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 3,563 | $1.01 | $3,598.63 |
DisclosureSEC source: 0001753926-24-000055 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 686,717 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 01:40 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 3,548 | $1.01 | $3,583.48 |
DisclosureSEC source: 0001753926-24-000055 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 683,154 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 22, 2023 Filed Dec 27, 2023 23:15 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 100 | $1.00 | $100.00 |
DisclosureSEC source: 0001753926-23-001648 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 679,606 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 21, 2023 Filed Dec 22, 2023 01:08 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 149,940 | $0.88 | $131,947.20 |
DisclosureSEC source: 0001753926-23-001621 · ownership.xml · nonDerivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 679,506 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 01:08 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 3,734 | $0.88 | $3,285.92 |
DisclosureSEC source: 0001753926-23-001621 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 529,566 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 01:08 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 198 | $0.86 | $170.28 |
DisclosureSEC source: 0001753926-23-001621 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,832 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 01:29 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 2,000 | $0.90 | $1,800.00 |
DisclosureSEC source: 0001753926-23-001595 · ownership.xml · nonDerivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,634 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 01:27 UTC |
Makes BrigidCFO
|
PurchaseCommon Stock | 1,000 | $0.87 | $870.00 |
DisclosureSEC source: 0001753926-23-001593 · ownership.xml · nonDerivative · entry 2 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 01:29 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 2,000 | $0.89 | $1,780.00 |
DisclosureSEC source: 0001753926-23-001595 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 523,634 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 01:27 UTC |
Makes BrigidCFO
|
PurchaseCommon Stock | 4,000 | $0.89 | $3,560.00 |
DisclosureSEC source: 0001753926-23-001593 · ownership.xml · nonDerivative · entry 1 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 01:29 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 301 | $0.88 | $264.88 |
DisclosureSEC source: 0001753926-23-001595 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,634 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 13, 2023 Filed Dec 14, 2023 00:46 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 858 | $0.87 | $746.46 |
DisclosureSEC source: 0001753926-23-001576 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,333 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 11, 2023 Filed Dec 14, 2023 00:46 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 28,948 | $0.89 | $25,763.72 |
DisclosureSEC source: 0001753926-23-001576 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520,475 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| December 06, 2023 Filed Dec 9, 2023 00:15 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 993 | $0.96 | $953.28 |
DisclosureSEC source: 0001753926-23-001571 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 491,527 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| November 24, 2023 Filed Nov 27, 2023 23:23 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 2,694 | $0.95 | $2,559.30 |
DisclosureSEC source: 0001753926-23-001541 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,534 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| November 22, 2023 Filed Nov 22, 2023 22:04 UTC |
Dwyer DonaldChief Business Officer
|
PurchaseCommon Stock | 1,000 | $0.96 | $960.00 |
DisclosureSEC source: 0001753926-23-001531 · ownership.xml · nonDerivative · entry 3 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 23:23 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 769 | $0.95 | $730.55 |
DisclosureSEC source: 0001753926-23-001541 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 487,840 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| November 22, 2023 Filed Aug 2, 2024 00:27 UTC |
Dwyer DonaldChief Business Officer
|
PurchaseCommon Stock | 2,000 | $0.96 | $1,920.00 |
DisclosureSEC source: 0001753926-24-001334 · primary_doc.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 22:04 UTC |
Dwyer DonaldChief Business Officer
|
PurchaseCommon Stock | 2,000 | $0.96 | $1,920.00 |
DisclosureSEC source: 0001753926-23-001531 · ownership.xml · nonDerivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 22:04 UTC |
Dwyer DonaldChief Business Officer
|
PurchaseCommon Stock | 2,500 | $0.96 | $2,400.00 |
DisclosureSEC source: 0001753926-23-001531 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 01:36 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,251 | $0.95 | $1,188.45 |
DisclosureSEC source: 0001753926-23-001511 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 487,071 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| November 16, 2023 Filed Nov 21, 2023 01:36 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 2,015 | $0.95 | $1,914.25 |
DisclosureSEC source: 0001753926-23-001511 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 485,820 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 24, 2023 Filed Oct 24, 2023 22:44 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,222 | $1.00 | $1,222.00 |
DisclosureSEC source: 0001753926-23-001382 · ownership.xml · nonDerivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,805 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 23, 2023 Filed Oct 24, 2023 22:44 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 100,565 | $1.00 | $100,565.00 |
DisclosureSEC source: 0001753926-23-001382 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,583 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 20, 2023 Filed Oct 24, 2023 22:44 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,581 | $1.00 | $1,581.00 |
DisclosureSEC source: 0001753926-23-001382 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,018 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 16, 2023 Filed Oct 16, 2023 22:12 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,600 | $1.00 | $1,600.00 |
DisclosureSEC source: 0001753926-23-001344 · ownership.xml · nonDerivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,437 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 22:12 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 9,414 | $1.01 | $9,508.14 |
DisclosureSEC source: 0001753926-23-001344 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,837 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 22:12 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,405 | $1.00 | $1,405.00 |
DisclosureSEC source: 0001753926-23-001344 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,423 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 09, 2023 Filed Oct 12, 2023 01:08 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 664 | $1.00 | $664.00 |
DisclosureSEC source: 0001753926-23-001316 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,018 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 06, 2023 Filed Oct 11, 2023 00:40 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 87,887 | $1.02 | $89,644.74 |
DisclosureSEC source: 0001753926-23-001314 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,354 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 05, 2023 Filed Oct 6, 2023 00:38 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,424 | $1.00 | $1,424.00 |
DisclosureSEC source: 0001753926-23-001304 · ownership.xml · nonDerivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,467 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 00:38 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 5,452 | $1.00 | $5,452.00 |
DisclosureSEC source: 0001753926-23-001304 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,043 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 03, 2023 Filed Oct 6, 2023 00:38 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 3,048 | $1.00 | $3,048.00 |
DisclosureSEC source: 0001753926-23-001304 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,591 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| October 02, 2023 Filed Oct 2, 2023 23:14 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 16,207 | $1.00 | $16,207.00 |
DisclosureSEC source: 0001753926-23-001285 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,543 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 28, 2023 Filed Oct 2, 2023 23:14 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 20,003 | $1.03 | $20,603.09 |
DisclosureSEC source: 0001753926-23-001285 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,336 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 27, 2023 Filed Sep 27, 2023 23:51 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,026 | $1.00 | $1,026.00 |
DisclosureSEC source: 0001753926-23-001273 · ownership.xml · nonDerivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,333 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.